CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...

Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

CRISPR Therapeutics AG (CRSP)’s share was trading at $40.97 as of March 18th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance. CRISPR Therapeutics ...

said Vertex and CRISPR, but there were no serious side effects linked to the therapy in the SCD group. There have also been no cases of cancer – a concern with bluebird's gene therapy approach.